Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First Line Hepato Cellular Carcinoma (HCC) clinical trial (NCT00858871). Contact the study team or your healthcare provider for specific answers.

Question 2

How does brivanib compare to sorafenib in terms of side effects and effectiveness?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First Line Hepato Cellular Carcinoma (HCC) clinical trial (NCT00858871). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks and benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First Line Hepato Cellular Carcinoma (HCC) clinical trial (NCT00858871). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for visits and treatments if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First Line Hepato Cellular Carcinoma (HCC) clinical trial (NCT00858871). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect in terms of monitoring my health during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First Line Hepato Cellular Carcinoma (HCC) clinical trial (NCT00858871). Contact the study team or your healthcare provider for specific answers.

Question 6

If I don't qualify for this trial, what other treatment options do I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First Line Hepato Cellular Carcinoma (HCC) clinical trial (NCT00858871). Contact the study team or your healthcare provider for specific answers.

What this study is about